MEDICAL MARIJUANA, INC. CEO TO SPEAK ON NUTRITIONAL AND THERAPEUTIC BENEFITS OF HEMP AT 3rd ANNUAL CANNABIS WORLD CONGRESS AND BUSINESS EXPO
RSHO Advocate Penny Howard to Share Story on How Her Fight to Save Daughter Harper Helped Legalize New Markets and Change Lives in Latin America
Medical Marijuana, Inc. (OTC: MJNA) today announced that at the 3rd Annual Cannabis World Congress and Business Expo (CWCBE) in New York on June 17, the Company’s CEO Dr. Stuart Titus will speak on how the world stands to benefit both nutritionally and therapeutically from Cannabidiol (CBD) – a nutritious, non-psychoactive substance derived from industrial hemp.
Medical Marijuana, Inc. subsidiary HempMeds® will also be showing retail-ready cannabis products and exhibiting at the Expo at booth #100, along with Dallas mom and Real Scientific Hemp Oil™ (RSHO™) advocate Penny Howard. Howard is attending the CWCBE to share the story of how her fight to save her daughter Harper led her on a Facebook crusade that helped legalize new markets in Latin America – changing millions of lives around the globe.
“The inspiring stories of brave mothers like Penny Howard, and children like Harper, is why the hard-working people at our Company get out of bed every morning,” Titus said. “I always look forward to an opportunity like the CWCBE where I can further educate audiences on the plethora of benefits for humanity that can be derived from one plant. We want to change the world’s perception of cannabis and people like Penny Howard and her little girl Harper are helping us accomplish our goal, while their conviction is helping others suffering across the globe.”
Penny Howard’s crusade to help other children who suffered like her daughter Harper opened the door for Medical Marijuana Inc. to export medical cannabis to Brazil and Mexico. As Reuters recently reported , the Mexican market for therapeutic cannabis may be worth up to $1-$2 billion for Medical Marijuana Inc.
New York dad Craig Pagano, the first-ever New York father to bring CBD hemp oil into the state to help save his daughter Beyla, will also be available at the CWCBE, as well as New York-based Kannalife Sciences, Inc ., which holds the exclusive license to the U.S. government patent on the therapeutic use of cannabinoids.
For more information about the CWCBE, visit http://www.cwcbexpo.com/ .
Public Relations Contact:
Chief Executive Officer
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC-MJNA (888-682-6562 )
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com .
The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market. To see Medical Marijuana, Inc.’s video statement, click here . Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.